The expansion addresses US injectable capacity shortages and growing demand for reliable domestic sterile manufacturing.

Mallinckrodt and Endo plan to combine their generic pharmaceuticals businesses and Endo's sterile injectables business after ...

The combination of Mallinckrodt and Endo will create a strong pharmaceutical company with a diversified portfolio, enhanced ...

Ireland’s Mallinckrodt will buy U.S. drugmaker Endo in a cash-and-stock deal valued at $6.7 billion. The companies said ...

Injectable drugs market is estimated to be valued at USD 614.07 Billion in 2025 and is expected to reach USD 1,032.78 Billion by 2032, CAGR of 7.7% , 2025-2032 BURLINGAME, CA, UNITED STATES, March ...

This expansion aims to address critical capacity shortages in the US injectable supply chain and meet the growing demand from pharmaceutical companies seeking reliable domestic sterile ...

The Noramco Group is investing $25M into its Halo Pharma facility in Whippany, NJ to establish sterile injectable ...

EAST WHITELAND — Endo, a pharmaceutical company that has its global headquarters in Chester County, is being acquired by ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...